Chronic daily headache in French children and adolescents

Pediatric Neurology
Jean-Christophe CuvellierLouis Vallée

Abstract

To characterize the clinical profile, comorbidity and aggravating factors, and outcomes, a consecutive series of 34 French children and adolescents with chronic daily headache was studied. Of 206 referred over an inclusive interval of 2 years for the evaluation of headaches, 34 merited a diagnosis of chronic daily headache, which was defined as persistent or daily headaches of at least 3 months in duration. The overwhelming majority were female (61.8%), with a mean age at diagnosis of 10.5+/-3.1 years (range, 2.9-14.8 years). According to the Silberstein-Lipton criteria, transformed migraine was the etiology in 61.8%, whereas according to the second edition of the International Classification of Headache Disorders, chronic migraine accounted for 50% of cases. Stressors were recognized in 82%. Analgesic abuse was evident in 52.9%. Of the 29 for whom follow-up information was available, headaches resolved or greatly improved in 93.1%. Children and adolescents with chronic daily headache are thus a small subset of children with headache seen in general ambulatory practice. They tend to be girls in the midteen years experiencing a transformed migraine complicated by analgesic abuse, suggesting potential preventability. Simple measu...Continue Reading

References

Feb 1, 1987·Headache·N T MathewF Perez
Aug 26, 1998·Archives of Disease in Childhood·D N Symon
Sep 11, 1998·Journal of Child Neurology·E VasconcellosJ S Warner
Mar 31, 2001·Headache·Y D Fragoso, P C Machado
Dec 12, 2001·Cephalalgia : an International Journal of Headache·I Abu-Arafeh
Aug 9, 2002·Headache·Matthew A KoenigUNKNOWN Pediatric Committee of the American Headache Society
May 25, 2004·Cephalalgia : an International Journal of Headache·S B Esposito, J L D Gherpelli
Jun 16, 2004·Cephalalgia : an International Journal of Headache·D Benzecry de AlmeidaM Prandini
Sep 21, 2004·Cephalalgia : an International Journal of Headache·F GalliV Guidetti
Dec 23, 2004·Headache·E L SpieringsM Sorbi
May 25, 2005·Cephalalgia : an International Journal of Headache·S D SilbersteinUNKNOWN International Headache Society
Jun 15, 2005·Headache·Natalie J WiendelsLaura A E M Laan
Sep 16, 2005·Cephalalgia : an International Journal of Headache·A Chakravarty
May 12, 2006·Cephalalgia : an International Journal of Headache·UNKNOWN Headache Classification CommitteeT J Steiner
Oct 12, 2007·Headache·Jean-Christophe CuvellierLouis Vallée

❮ Previous
Next ❯

Citations

Sep 4, 2008·Current Pain and Headache Reports·Christine L Lay, Susan W Broner
Sep 20, 2011·The American Journal of Clinical Hypnosis·Daniel P Kohen
Feb 14, 2014·Current Pain and Headache Reports·Matteo Chiappedi, Umberto Balottin
Mar 21, 2009·The Journal of Headache and Pain·Jean-Christophe CuvellierStéphane Auvin
Dec 2, 2008·Revue neurologique·J-C Cuvellier
Nov 4, 2008·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·J-C CuvellierL Vallée
Jul 25, 2012·Headache·Fausta PiazzaUmberto Balottin
Feb 26, 2013·Headache·Jean-Christophe CuvellierLouis Vallée
Aug 18, 2010·Cephalalgia : an International Journal of Headache·Marco A ArrudaMarcelo E Bigal
Sep 21, 2018·Current Opinion in Pediatrics·Shalonda K SlaterHope L O'Brien
Nov 10, 2010·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Shashi S SeshiaCiçek Wöber-Bingöl
Mar 21, 2019·Frontiers in Neurology·Laura PapettiMassimiliano Valeriani
May 7, 2009·Current Opinion in Neurology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.